Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Double-blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the 12-week Efficacy of Vagitocin in Postmenopausal Women With Symptoms of Vulvovaginal Atrophy

NCT04629885 is registered in ClinicalTrials.gov with PepTonic Medical AB as lead sponsor.

NCT NCT04629885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04629885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Double-blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the 12-week Efficacy of Vagitocin in Postmenopausal Women With Symptoms of Vulvovaginal Atrophy
Lead sponsor
PepTonic Medical AB
Phase
Phase 2
Overall status
Completed
Start date
May 3, 2016
Completion date
May 3, 2017
Enrollment
202 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

vulvovaginal atrophy